Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) PT at $53.29

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been assigned a consensus rating of “Moderate Buy” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and six have given a buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $53.2857.

Separately, Zacks Research downgraded shares of Astrana Health from a “strong-buy” rating to a “strong sell” rating in a research report on Monday, September 1st.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Two Sigma Investments LP purchased a new position in Astrana Health during the 4th quarter worth $466,000. Dimensional Fund Advisors LP grew its position in Astrana Health by 10.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company’s stock worth $32,968,000 after purchasing an additional 101,192 shares during the last quarter. Hussman Strategic Advisors Inc. grew its position in Astrana Health by 33.3% during the 1st quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock worth $2,605,000 after purchasing an additional 21,000 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Astrana Health by 6.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock worth $15,490,000 after purchasing an additional 28,200 shares during the last quarter. Finally, Northern Trust Corp grew its position in Astrana Health by 10.1% during the 4th quarter. Northern Trust Corp now owns 467,179 shares of the company’s stock worth $14,730,000 after purchasing an additional 43,032 shares during the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Trading Down 3.6%

NASDAQ ASTH opened at $29.70 on Wednesday. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. The firm’s fifty day moving average price is $26.48 and its 200 day moving average price is $28.21. The company has a market capitalization of $1.66 billion, a price-to-earnings ratio of 58.24, a price-to-earnings-growth ratio of 0.77 and a beta of 0.85. Astrana Health has a 12 month low of $21.20 and a 12 month high of $63.20.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, August 7th. The company reported $0.19 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.17). The company had revenue of $654.81 million during the quarter, compared to analysts’ expectations of $639.13 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company’s quarterly revenue was up 34.7% on a year-over-year basis. During the same period last year, the business earned $0.40 earnings per share. Astrana Health has set its Q3 2025 guidance at EPS. On average, sell-side analysts expect that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.